165 related articles for article (PubMed ID: 10898736)
1. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells.
Wei LH; Jacobs AT; Morris SM; Ignarro LJ
Am J Physiol Cell Physiol; 2000 Jul; 279(1):C248-56. PubMed ID: 10898736
[TBL] [Abstract][Full Text] [Related]
2. IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells.
Wei LH; Yang Y; Wu G; Ignarro LJ
Am J Physiol Cell Physiol; 2008 May; 294(5):C1198-205. PubMed ID: 18367589
[TBL] [Abstract][Full Text] [Related]
3. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production.
Chang CI; Zoghi B; Liao JC; Kuo L
J Immunol; 2000 Aug; 165(4):2134-41. PubMed ID: 10925299
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells.
Teng X; Zhang H; Snead C; Catravas JD
Am J Physiol Cell Physiol; 2002 Jan; 282(1):C144-52. PubMed ID: 11742807
[TBL] [Abstract][Full Text] [Related]
5. Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation.
Wei LH; Wu G; Morris SM; Ignarro LJ
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9260-4. PubMed ID: 11470919
[TBL] [Abstract][Full Text] [Related]
6. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and IL-10 inhibit induction of IL-1 receptor type I and type II gene expression by IL-4 and IL-13 in human monocytes.
Dickensheets HL; Donnelly RP
J Immunol; 1997 Dec; 159(12):6226-33. PubMed ID: 9550426
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid inhibition of interleukin-4 (IL-4) and interleukin-13 (IL-13) induced up-regulation of arginase in rat airway fibroblasts.
Lindemann D; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):546-50. PubMed ID: 14618299
[TBL] [Abstract][Full Text] [Related]
9. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells.
Watanabe S; Mu W; Kahn A; Jing N; Li JH; Lan HY; Nakagawa T; Ohashi R; Johnson RJ
Am J Nephrol; 2004; 24(4):387-92. PubMed ID: 15256805
[TBL] [Abstract][Full Text] [Related]
10. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
Reichel M; Nelson BH; Greenberg PD; Rothman PB
J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors suppress endotoxin- and IL-1 beta-induced NO synthesis in aortic smooth muscle cells.
Marczin N; Papapetropoulos A; Catravas JD
Am J Physiol; 1993 Sep; 265(3 Pt 2):H1014-8. PubMed ID: 8214107
[TBL] [Abstract][Full Text] [Related]
12. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide.
Wileman SM; Mann GE; Baydoun AR
Br J Pharmacol; 1995 Dec; 116(8):3243-50. PubMed ID: 8719803
[TBL] [Abstract][Full Text] [Related]
13. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE
Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid.
Chen CW; Chao Y; Chang YH; Hsu MJ; Lin WW
Br J Pharmacol; 2002 Dec; 137(7):1011-20. PubMed ID: 12429573
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages.
Klasen S; Hammermann R; Fuhrmann M; Lindemann D; Beck KF; Pfeilschifter J; Racké K
Br J Pharmacol; 2001 Mar; 132(6):1349-57. PubMed ID: 11250887
[TBL] [Abstract][Full Text] [Related]
16. Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.
Gingras S; Simard J
Endocrinology; 1999 Oct; 140(10):4573-84. PubMed ID: 10499513
[TBL] [Abstract][Full Text] [Related]
17. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.
Dickensheets HL; Venkataraman C; Schindler U; Donnelly RP
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10800-5. PubMed ID: 10485906
[TBL] [Abstract][Full Text] [Related]
18. Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1.
Yu JY; Lee JJ; Lim Y; Kim TJ; Jin YR; Sheen YY; Yun YP
J Pharmacol Sci; 2008 May; 107(1):90-8. PubMed ID: 18490856
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages.
Paludan SR; Ellermann-Eriksen S; Lovmand J; Mogensen SC
Scand J Immunol; 1999 Feb; 49(2):169-76. PubMed ID: 10075021
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1.
Horiuchi M; Hayashida W; Akishita M; Yamada S; Lehtonen JY; Tamura K; Daviet L; Chen YE; Hamai M; Cui TX; Iwai M; Minokoshi Y
Circ Res; 2000 Feb; 86(2):233-40. PubMed ID: 10666420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
